Remplir™
Peripheral nerve repair
CommercialFDA cleared; EU/UK regulatory submissions pending
Key Facts
Indication
Peripheral nerve repair
Phase
Commercial
Status
FDA cleared; EU/UK regulatory submissions pending
Company
About Orthocell
Regenerative medicine firm delivering collagen devices and autologous cell therapies for musculoskeletal and nerve repair.
View full company profileTherapeutic Areas
Other Peripheral nerve repair Drugs
| Drug | Company | Phase |
|---|---|---|
| NovoSorb Synthetic Nerve Guide | PolyNovo | Pre-Clinical |